[Evaluation of rest-activity rhythms in advanced non-small-cell lung cancer (NSCLC) patients. Importance of corticotherapy?]

C Focan; C Mormont; N Moeneclaye; D Focan-Henrard; J Waterhouse

doi:10.1016/s0369-8114(03)00041-5

[Evaluation of rest-activity rhythms in advanced non-small-cell lung cancer (NSCLC) patients. Importance of corticotherapy?]

Pathol Biol (Paris). 2003 Jun;51(4):206-7. doi: 10.1016/s0369-8114(03)00041-5.

[Article in French]

Authors

C Focan¹, C Mormont, N Moeneclaye, D Focan-Henrard, J Waterhouse

Affiliation

¹ Service d'oncologie médicale, clinique Saint-Joseph, rue de Hesbaye 75, 4000, Liège, Belgique. [email protected]

PMID: 12852990
DOI: 10.1016/s0369-8114(03)00041-5

Abstract

The circadian structure (i.e. rest-activity cycle) was evaluated by actometry in a group of 25 advanced NSCLC patients. A better circadian profile was observed in the 6 patients treated with corticosteroïds. However those patients had also a shortened survival.

Publication types

English Abstract

MeSH terms

Adrenal Cortex Hormones / pharmacology*
Adrenal Cortex Hormones / therapeutic use
Carcinoma, Non-Small-Cell Lung / drug therapy
Carcinoma, Non-Small-Cell Lung / physiopathology*
Chronotherapy*
Circadian Rhythm* / drug effects
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / physiopathology*
Motor Activity / drug effects

Substances

Adrenal Cortex Hormones